Roche Holding Ltd
Brak transakcji
Brak transakcji
Korporacyjne papiery dłużne
Poniżej znajduje się lista obligacji Roche Holding Ltd, posortowana według wskaźnika yield to worst. Inwestorzy często wybierają obligacje spółek ze względu na ich większą stabilność w okresach zmienności rynkowej. Analizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTW % | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Rating S&P | Ocena kredytowa Fitch | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| CCHGCY3666852Genentech, Inc. 5.25% 15-JUL-2035 | 5,67% | 97,00% | 5,250% | 2035-07-15 | 288,45 M USD | 1 000,00 USD | NR | — | Genentech, Inc. |
 CHGCY5766486Roche Holdings, Inc. 5.218% 08-MAR-2054 | 5,65% | 93,94% | 5,218% | 2054-03-08 | 1,6 B USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY5317644Roche Holdings, Inc. 2.607% 13-DEC-2051 | 5,62% | 59,45% | 2,607% | 2051-12-13 | 2 B USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY4184535Roche Holdings, Inc. 4.0% 28-NOV-2044 | 5,37% | 84,00% | 4,000% | 2044-11-28 | 650,2 M USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY4391962Roche Holdings, Inc. 7.0% 01-MAR-2039 | 5,31% | 115,42% | 7,000% | 2039-03-01 | 1,12 B USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY6244754Roche Holdings, Inc. 4.666% 02-DEC-2035 | 5,08% | 96,90% | 4,666% | 2035-12-02 | 800 M USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5766484Roche Holdings, Inc. 4.985% 08-MAR-2034 | 4,95% | 100,18% | 4,985% | 2034-03-08 | 1,25 B USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5698748Roche Holdings, Inc. 5.593% 13-NOV-2033 | 4,93% | 103,87% | 5,593% | 2033-11-13 | 1,6 B USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5885612Roche Holdings, Inc. 4.592% 09-SEP-2034 | 4,81% | 97,57% | 4,592% | 2034-09-09 | 1 B USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY6244752Roche Holdings, Inc. 4.374% 02-DEC-2032 | 4,75% | 97,93% | 4,374% | 2032-12-02 | 600 M USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY5698943Roche Holdings, Inc. 5.489% 13-NOV-2030 | 4,62% | 103,26% | 5,489% | 2030-11-13 | 1,25 B USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5317198Roche Holdings, Inc. 2.076% 13-DEC-2031 | 4,61% | 87,91% | 2,076% | 2031-12-13 | 2 B USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| USU75000BL9Roche Holdings, Inc. 2.375% 28-JAN-2027 | 4,59% | 98,79% | 2,375% | 2027-01-28 | 850 M USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY6244750Roche Holdings, Inc. 4.075% 02-DEC-2030 | 4,56% | 98,24% | 4,075% | 2030-12-02 | 500 M USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| USU75000BP0Roche Holdings, Inc. 3.625% 17-SEP-2028 | 4,51% | 98,15% | 3,625% | 2028-09-17 | 650 M USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| USU75000BV7Roche Holdings, Inc. 2.314% 10-MAR-2027 | 4,48% | 98,60% | 2,314% | 2027-03-10 | 1,25 B USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5766482Roche Holdings, Inc. 4.909% 08-MAR-2031 | 4,47% | 101,76% | 4,909% | 2031-03-08 | 750 M USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5885610Roche Holdings, Inc. 4.203% 09-SEP-2029 | 4,40% | 99,41% | 4,203% | 2029-09-09 | 900 M USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY5766480Roche Holdings, Inc. 4.79% 08-MAR-2029 | 4,39% | 100,99% | 4,790% | 2029-03-08 | 875,2 M USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5317643Roche Holdings, Inc. 1.93% 13-DEC-2028 | 4,32% | 94,47% | 1,930% | 2028-12-13 | 2 B USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| CHGCY5698942Roche Holdings, Inc. 5.338% 13-NOV-2028 | 4,24% | 102,00% | 5,338% | 2028-11-13 | 1,25 B USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |
| CHGCY5698948Roche Holdings, Inc. 5.265% 13-NOV-2026 | 4,17% | 100,27% | 5,265% | 2026-11-13 | 1,1 B USD | 1 000,00 USD | AA | — | Roche Holdings, Inc. |
| XXS2813211617Roche Finance Europe BV 3.564% 03-MAY-2044 | 4,02% | 94,26% | 3,564% | 2044-05-03 | 850 M EUR | 1 000,00 EUR | AA | AA | Roche Finance Europe BV |
| XXS272633509Roche Finance Europe BV 3.586% 04-DEC-2036 | 3,68% | 99,15% | 3,586% | 2036-12-04 | 900 M EUR | 1 000,00 EUR | AA | AA | Roche Finance Europe BV |
| XXS259208840Roche Finance Europe BV 3.355% 27-FEB-2035 | 3,46% | 99,19% | 3,355% | 2035-02-27 | 500 M EUR | 1 000,00 EUR | AA | AA | Roche Finance Europe BV |
| XXS281321129Roche Finance Europe BV 3.227% 03-MAY-2030 | 3,06% | 100,55% | 3,227% | 2030-05-03 | 650 M EUR | 1 000,00 EUR | AA | AA | Roche Finance Europe BV |
| XXS259208823Roche Finance Europe BV 3.204% 27-AUG-2029 | 2,97% | 100,64% | 3,204% | 2029-08-27 | 750 M EUR | 1 000,00 EUR | AA | AA | Roche Finance Europe BV |
| XXS272633193Roche Finance Europe BV 3.312% 04-DEC-2027 | 2,81% | 100,62% | 3,312% | 2027-12-04 | 600 M EUR | 1 000,00 EUR | AA | AA | Roche Finance Europe BV |
| CCH137173682Roche Kapitalmarkt AG 1.17% 06-SEP-2039 | 1,34% | 97,96% | 1,170% | 2039-09-06 | 275 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| CCH147485703Roche Kapitalmarkt AG 1.13% 27-AUG-2040 | 1,32% | 96,94% | 1,130% | 2040-08-27 | 185 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| AA3LRKJRoche Kapitalmarkt AG 1.95% 15-SEP-2038 | 1,18% | 108,68% | 1,950% | 2038-09-15 | 230 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| AA3K2NXRoche Kapitalmarkt AG 1.0% 25-FEB-2037 | 1,13% | 98,71% | 1,000% | 2037-02-25 | 300 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| CCH137173681Roche Kapitalmarkt AG 1.0975% 06-SEP-2034 | 1,07% | 100,20% | 1,098% | 2034-09-06 | 420 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| CCH1474857021Roche Kapitalmarkt AG 0.8775% 27-AUG-2035 | 1,05% | 98,49% | 0,878% | 2035-08-27 | 255 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| AA3LRKKRoche Kapitalmarkt AG 1.75% 15-SEP-2033 | 0,89% | 105,97% | 1,750% | 2033-09-15 | 190 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| AA3K88ARoche Kapitalmarkt AG 2.0% 23-SEP-2032 | 0,80% | 107,24% | 2,000% | 2032-09-23 | 375 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| RROK222Roche Kapitalmarkt AG 0.75% 25-FEB-2031 | 0,77% | 100,10% | 0,750% | 2031-02-25 | 625 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| RROK127Roche Kapitalmarkt AG 0.75% 24-SEP-2030 | 0,70% | 100,20% | 0,750% | 2030-09-24 | 400 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| CCH1474857013Roche Kapitalmarkt AG 0.4625% 27-MAY-2030 | 0,69% | 99,14% | 0,463% | 2030-05-27 | 335 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| CCH137173680Roche Kapitalmarkt AG 0.985% 06-SEP-2029 | 0,64% | 101,08% | 0,985% | 2029-09-06 | 250 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| RROK125Roche Kapitalmarkt AG 0.45% 23-MAR-2029 | 0,54% | 99,90% | 0,450% | 2029-03-23 | 350 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| AA3K2JZRoche Kapitalmarkt AG 0.5% 25-FEB-2027 | 0,53% | 99,98% | 0,500% | 2027-02-25 | 825 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| AA3LQ44Roche Kapitalmarkt AG 1.6% 15-SEP-2028 | 0,53% | 102,33% | 1,600% | 2028-09-15 | 140 M CHF | 5 000,00 CHF | AA | AA | Roche Kapitalmarkt AG |
| CHGCY5698672Roche Holdings, Inc. FRN 13-NOV-2026 | — | 100,17% | 4,359% | 2026-11-13 | 300 M USD | 1 000,00 USD | AA | AA | Roche Holdings, Inc. |